CCR8 and neoplasm: On another equally important note, 40% of peripheral blood CCR8+ Tregs are phenotypically similar to tumor-infiltrating CCR8+ Tregs and share many TCR clonotypes (114, 115), which suggests that tumor-specific Tregs recirculate between the tumor tissue and blood compartments, providing a rationale for targeting CCR8 on circulating Tregs.